José A. Fontenla

717 total citations
36 papers, 610 citations indexed

About

José A. Fontenla is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, José A. Fontenla has authored 36 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 13 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in José A. Fontenla's work include Synthesis and Reactivity of Heterocycles (7 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). José A. Fontenla is often cited by papers focused on Synthesis and Reactivity of Heterocycles (7 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). José A. Fontenla collaborates with scholars based in Spain, Italy and Portugal. José A. Fontenla's co-authors include Emilia Rivas, Alfonso Fernández‐Mayoralas, C. FERNANDEZ, Lourdes Santana, Marı́a L. de Ceballos, Dolores Viña, Enrique Raviña, Eugenio Uriarte, María João Matos and Marı́a Isabel Loza and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

José A. Fontenla

35 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José A. Fontenla Spain	16	306	231	130	106	75	36	610
Gisella Terre’Blanche South Africa	15	278 0.9×	210 0.9×	93 0.7×	80 0.8×	49 0.7×	47	573
Y. Kondou Japan	4	209 0.7×	333 1.4×	183 1.4×	73 0.7×	95 1.3×	7	719
Se‐Young Son South Korea	4	208 0.7×	268 1.2×	181 1.4×	98 0.9×	87 1.2×	7	631
E. FERNANDEZ‐ALVAREZ Spain	18	566 1.8×	205 0.9×	110 0.8×	78 0.7×	46 0.6×	52	786
Jong‐Hyun Park South Korea	15	228 0.7×	291 1.3×	161 1.2×	79 0.7×	62 0.8×	39	752
Frédéric Ooms Belgium	10	339 1.1×	210 0.9×	252 1.9×	42 0.4×	194 2.6×	25	705
Ulrike Thull Switzerland	14	272 0.9×	210 0.9×	160 1.2×	140 1.3×	43 0.6×	16	677
Francesco Campagna Italy	16	432 1.4×	214 0.9×	205 1.6×	67 0.6×	152 2.0×	39	714
Nuria Fraiz Spain	11	397 1.3×	174 0.8×	124 1.0×	34 0.3×	30 0.4×	17	674
Umberto Maria Battisti Italy	16	362 1.2×	383 1.7×	98 0.8×	140 1.3×	31 0.4×	68	808

Countries citing papers authored by José A. Fontenla

Since Specialization

Citations

This map shows the geographic impact of José A. Fontenla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Fontenla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Fontenla more than expected).

Fields of papers citing papers by José A. Fontenla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Fontenla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Fontenla. The network helps show where José A. Fontenla may publish in the future.

Co-authorship network of co-authors of José A. Fontenla

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Fontenla. A scholar is included among the top collaborators of José A. Fontenla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Fontenla. José A. Fontenla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poser, Gilsane Lino von, et al.. (2025). In Silico and In Vivo Pharmacological Evaluation of Iridoid Compounds: Geniposide and Asperuloside Profile Study Through Molecular Docking Assay and in the Caenorhabditis elegans Model. Biomolecules. 15(8). 1105–1105.

Rott, Marilise Brittes, et al.. (2024). Toxicological assessment of the Achyrocline satureioides aqueous extract in the Caenorhabditis elegans alternative model. Journal of Toxicology and Environmental Health. 87(18). 730–751. 1 indexed citations

Matos, María João, Lucía Ordóñez Mayán, Eugenio Uriarte, et al.. (2023). 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies. European Journal of Medicinal Chemistry. 248. 115091–115091. 6 indexed citations

Pereira, Patrı́cia, Marı́a Isabel Loza, José Brea, et al.. (2021). Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug. European Journal of Pharmacology. 906. 174276–174276. 3 indexed citations

Viña, Dolores, et al.. (2020). Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson’s disease: Synthesis, in vitro and in vivo studies. Bioorganic Chemistry. 101. 103986–103986. 16 indexed citations

Delogu, Giovanna, Francesca Pintus, Lucía Ordóñez Mayán, et al.. (2017). MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations. MedChemComm. 8(9). 1788–1796. 18 indexed citations

Cebey‐López, Miriam, José A. Fontenla, Eugenio Uriarte, Lourdes Santana, & Eduardo Sobarzo‐Sánchez. (2013). Comparison of the Antidepressive Effects of Trans-Resveratrol and 5-Methoxy-7H-Dibenzo[de,h]Quinolin-7-One. Current Topics in Medicinal Chemistry. 14(2). 234–238. 3 indexed citations

Matos, María João, Santiago Vilar, Eugenio Uriarte, et al.. (2013). Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. European Journal of Medicinal Chemistry. 63. 151–161. 55 indexed citations

FERNANDEZ, C., et al.. (2003). Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1Electronic supplementary information (ESI) available: experimental details for the preparation of all derivatives and biological assays. See http://www.rsc.org/suppdata/ob/b2/b212066f/. Organic & Biomolecular Chemistry. 1(5). 767–771. 60 indexed citations

10.

González‐Gómez, José C., Lourdes Santana, Eugenio Uriarte, et al.. (2003). New arylpiperazine derivatives with high affinity for α1A, D2 and 5-HT2A receptors. Bioorganic & Medicinal Chemistry Letters. 13(2). 175–178. 31 indexed citations

11.

FERNANDEZ, C., et al.. (2000). Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents. Carbohydrate Research. 327(4). 353–365. 63 indexed citations

12.

Claudi, Francesco, Antonio Di Stefano, Gianfabio Giorgioni, et al.. (2000). Binding and Preliminary Evaluation of 5-Hydroxy- and 10-Hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as Dopamine Receptor Ligands. Journal of Medicinal Chemistry. 43(4). 599–608. 17 indexed citations

13.

Masaguer, Christian F., et al.. (1998). Butyrophenone analogues in the carbazole series: Synthesis and determination of affinities at D2 and 5-HT2A receptors. Bioorganic & Medicinal Chemistry Letters. 8(24). 3571–3576. 10 indexed citations

14.

Raviña, Enrique, et al.. (1996). Synthesis and Affinities for Dopamine (D2) and 5-Hydroxytryptamine (5-HT2A Receptors of 1-(Benzoylpropyl)-4-(1-oxocycloalkyl-2-ethyl)- piperazines as Cyclic Butyrophenone Derivatives.. Chemical and Pharmaceutical Bulletin. 44(3). 534–541. 13 indexed citations

15.

Masaguer, Christian F., José M. Cid, José A. Fontenla, et al.. (1995). Butyrophenone analogues: Synthesis of 2-methyl-3-ethyl-5-aminoethyl-4,5,6,7-tetrahydroindol-4-ones, and their affinities for d1, d2 and 5-ht2a receptors. Bioorganic & Medicinal Chemistry Letters. 5(6). 579–584. 5 indexed citations

16.

Fontenla, José A., et al.. (1994). Synthesis and Atypical Antipsychotic Profile of Some 2-(2-Piperidinoethyl)benzocycloalkanones as Analogs of Butyrophenone. Journal of Medicinal Chemistry. 37(16). 2564–2573. 33 indexed citations

17.

Castro, Elena, et al.. (1994). Pyridazine derivatives XII. Synthesis and antipsychotic-antidepressant activity of some butyrophenone derivatives of 6-phenylpyridazine. European Journal of Medicinal Chemistry. 29(11). 831–839. 7 indexed citations

18.

Gil‐Longo, José, Reyes Laguna, Ignácio Verde, et al.. (1993). Pyridazine Derivatives. XI: Antihypertensive Activity of 3-Hydrazinocycloheptyl[1,2-c]pyridazine and Its Hydrazone Derivatives. Journal of Pharmaceutical Sciences. 82(3). 286–290. 30 indexed citations

19.

Loza, Marı́a Isabel, Ferrán Sanz, Marı́a Isabel Cadavid, et al.. (1993). Cyproheptadine Analogues: Synthesis, Antiserotoninergic Activity, and Structure-Activity Relationships. Journal of Pharmaceutical Sciences. 82(11). 1090–1093. 1 indexed citations

20.

Orallo, Francisco, José A. Fontenla, Marı́a Isabel Loza, Manuel Campos‐Toimil, & J. M. Calleja. (1992). Effect of urethane on hydralazine-induced tachycardia in rats. General Pharmacology The Vascular System. 23(6). 1143–1147. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact